Tau is essential to β-amyloid-induced neurotoxicity
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Senile plaques and neurofibrillary tangles, the two hallmark lesions of Alzheimer's disease, are the results of the pathological deposition of proteins normally present throughout the brain. Senile plaques are extracellular deposits of fibrillar β-amyloid peptide (Aβ); neurofibrillary tangles represent intracellular bundles of self-assembled hyperphosphorylated tau proteins. Although these two lesions are often present in the same brain areas, a mechanistic link between them has yet to be established. In the present study, we analyzed whether tau plays a key role in fibrillar Aβ-induced neurite degeneration in central neurons. Cultured hippocampal neurons obtained from wild-type, tau knockout, and human tau transgenic mice were treated with fibrillar Aβ. Morphological analysis indicated that neurons expressing either mouse or human tau proteins degenerated in the presence of Aβ. On the other hand, tau-depleted neurons showed no signs of degeneration in the presence of Aβ. These results provide direct evidence supporting a key role for tau in the mechanisms leading to Aβ-induced neurodegeneration in the central nervous system. In addition, the analysis of the composition of the cytoskeleton of tau-depleted neurons suggested that the formation of more dynamic microtubules might confer resistance to Aβ-mediated neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations support the idea that Aβ and Tau act together and that Aβ is upstream of Tau [114,115], positioning Aβ as the initiator and Tau as the executor in the pathogenetic process [116].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [115]
In the citing paper
“Indeed, Tau has been implicated in the synaptotoxicity induced by Aβ exposure [102].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [102]
In the citing paper
“Thus, cultured neurons from tau knockout (Tau−/−) mice are not susceptible to Aβ-induced synaptic damage and neurotoxicity (Rapoport et al., 2002; Nussbaum et al., 2012; Zempel et al., 2013) or to Aβ-induced defects in axonal transport (Vossel et al., 2011).”
From Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice (2017) · cites this paper as Rapoport et al., 2002
In the citing paper
“Neurons without tau are resistant to Aβ toxicity, and APP transgenic mice lacking tau develop Aβ pathology but remain cognitively normal (Rapoport et al., 2002; Roberson et al., 2007).”
From CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease (2018) · cites this paper as Rapoport et al., 2002
In the citing paper
“Data from cell and animal models show that tau is also a mediator of Aβ-induced toxicity46–48.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [46]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Assay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,179
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Bottenstein, J. E., & Sato, G. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.514 · Cited by 2,276
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,459
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Research works printed but not linked: 2
- M P Vitek, C G Rasool, F de Sauvage, S M Vitek, R T Bartus, B Beer, R A Ashton, A F Macq, J M Maloteaux, A J Blume Brain Res 464, 121–131 (1988).
- J G Wood, S S Mirra, N L Pollock, L I Binder Proc Natl Acad Sci USA 508, 320–324 (1986).
Cited by
Items 601–700 of 971
Alzheimer’s Disease and Its Possible Evolutionary Origin: Hypothesis
Whitfield, J. F., Rennie, K., & Chakravarthy, B. (2023) · Cells · doi:10.3390/cells12121618 · Cited by 12
Untangling the role of tau in Alzheimer’s disease: A unifying hypothesis
Bhatia, N. S., & Hall, G. F. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0114-5 · Cited by 12
Nam, Y., Joo, B., Lee, J., Han, K., Ryu, K., Koh, Y. H., Kim, J., Koo, J. W., We, Y.-M., & Hoe, H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00192 · Cited by 12
Kanaan, N. M., Himmelstein, D. S., Ward, S., Combs, B., & Binder, L. I. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00056-1 · Cited by 12
Self-citationKumar, H., & Udgaonkar, J. B. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.04.004 · Cited by 12
Deciphering the Role of ATP on PHF6 Aggregation
Pal, S., Roy, R., & Paul, S. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c01768 · Cited by 12
Santiago, F. E., Almeida, M. C., & Carrettiero, D. C. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0579-5 · Cited by 12
Alzheimer’s disease: from molecular pathogenesis to innovative therapies
Scarpini, E. A., & Cogiamanian, F. M. (2003) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.3.5.619 · Cited by 12
Zhang, Z., Zhao, R., Tang, Y., Wen, S., Wang, D., & Qi, J. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0405-6 · Cited by 11
“... microtubuleassociated protein tau [2, 3]. Although the relationship between the two lesions remains to be completely elucidated, it is generally believed that Ab induces the hyperphosphorylation of tau, both in vitro and in vivo [4–6], leading to the destabilization of microtubules, impairment of axonal transport…”
RetractedYao, J., He, Z., You, G., Liu, Q., & Li, N. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080402 · Cited by 11
Early Chronic Stress Induced Changes within the Locus Coeruleus in Sporadic Alzheimer’s Disease
Minné, D., Marnewick, J. L., & Engel-Hills, P. C. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230811092956 · Cited by 11
Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target
López-Hernández, R., de la Torre-Álamo, M. M., García-Bueno, B., Baroja‐Mazo, A., Fenoy, F. J., & Cuevas, S. (2025) · Antioxidants · doi:10.3390/antiox14020121 · Cited by 11
Immunization therapy for Alzheimer disease?
Bennett, D. A., & Holtzman, D. M. (2005) · Neurology · doi:10.1212/01.wnl.0000150527.24596.29 · Cited by 11
Exercise and Alzheimer's: The body as a whole
Guerra, Y. D. S., Montesdeoca, S. S., Manso, J. M. G., González, J. M. M., Valdivielso, M. E. N., Ruiz, D. R., Matoso, D. R., & Escudero, M. Q. (2016) · Revista Andaluza de Medicina del Deporte · doi:10.1016/j.ramd.2015.11.002 · Cited by 11
The Role of Anionic Peptide Fragments in 1N4R Human Tau Protein Aggregation
Khalili, M., Riazi, G. H., Ahmadian, S., Khodarahmi, R., Khodadadi, S., Afrasiabi, A., Karima, O., Mokhtari, F., & Hoveizi, E. (2014) · Protein and Peptide Letters · doi:10.2174/0929866521666131223120713 · Cited by 11
Mazahir, F., Rahi, V., Kaundal, R. K., Alam, M. I., & Yadav, A. K. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.158197 · Cited by 10
New Beginnings in Alzheimer’s Disease: The Most Prevalent Tauopathy
Hernández, F., Llorens-Martín, M., Bolós, M., Pérez, M., Cuadros, R., Pallas‐Bazarra, N., Zabala, J. C., & Ávila, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179916 · Cited by 10
Alzheimer’s disease: ageing-related or age-related? New hypotheses from an old debate
Bugiani, O. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0614-4 · Cited by 10
Fluid biomarkers in cerebral amyloid angiopathy
Savar, S. M., Ma, B., Hone, E., Jahan, F., Markovic, S. J., Pedrini, S., Shemehsavar, S., Easwaran, V., Taddei, K., Gardener, S. L., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1347320 · Cited by 10
Hypothermia as a risk factor for Alzheimer disease
Almeida, M. C., & Carrettiero, D. C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64074-1.00044-6 · Cited by 10
Mass spectrometry-based neurochemical analysis: perspectives for primate research
Zhang, X., Rauch, A., Xiao, H., Rainer, G., & Logothetis, N. K. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.5.641 · Cited by 10
Molecular Determinants of Alzheimer’s Disease Aβ Peptide Neurotoxicity
Cappai, R., & Barnham, K. J. (2007) · Future Neurology · doi:10.2217/14796708.2.4.397 · Cited by 9
Derailed Intraneuronal Signalling Drives Pathogenesis in Sporadic and Familial Alzheimer’s Disease
Dooren, T. V., Princen, K., Witte, K. D., & Griffioen, G. (2014) · BioMed Research International · doi:10.1155/2014/167024 · Cited by 9
Evidence for early identification of Alzheimer's diseasePreprint
Alexiou, A. T., & Vlamos, P. (2012) · arXiv (Cornell University) · doi:10.48550/arxiv.1209.4223 · Cited by 9
Ré, R. N. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182a28af3 · Cited by 9
Korde, D. S., & Humpel, C. (2024) · Biomolecules · doi:10.3390/biom14020165 · Cited by 9
Variable tau accumulation in murine models with abnormal prion protein deposits
Piccardo, P., King, D., Brown, D., & Barron, R. M. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.10.040 · Cited by 9
Afreen, S., & Ferreira, A. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.05.046 · Cited by 9
Self-citationDuan, J., Marcellus, K. A., Qin, X., Wang, Y., & Paudel, H. K. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.03.009 · Cited by 9
Zhang, Z., Zhao, R., Tang, Y., Wen, S., Wang, D., & Qi, J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0721-5 · Cited by 9
Ligand‐Induced Flocculation of Neurotoxic Fibrillar Aβ(1–42) by Noncovalent Crosslinking
Hetényi, A., Fülöp, L., Martinek, T. A., Wéber, E., Soós, K., & Penke, B. (2008) · ChemBioChem · doi:10.1002/cbic.200700351 · Cited by 9
The influence of aging in one tauopathy: Alzheimer 's disease.
Ávila, J. (2004) · PubMed · Cited by 9
Socio-Demographic Factors Linked to Psychological Well-Being in Dementia Caregivers
Tatomirescu, L. F., Glavce, C. S., Prada, G. I., Borosanu, A., & Turcu, S. (2025) · Healthcare · doi:10.3390/healthcare13172235 · Cited by 8
A Mutant Variant of E2F4 Triggers Multifactorial Therapeutic Effects in 5xFAD Mice
López‐Sánchez, N., Ramón‐Landreau, M., Trujillo, C., Garrido‐García, A., & Frade, J. M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02764-z · Cited by 8
Mondal, R., Deb, S., Shome, G., Sarkar, V., Lahiri, D., Datta, S. S., & Benito‐León, J. (2024) · Neurología · doi:10.1016/j.nrl.2023.11.005 · Cited by 8
Aβ oligomer induced cognitive impairment and evaluation of ACU193‐MNS‐based MRI in rabbit
Rozema, N. B., Procissi, D., Bertolino, N., Viola, K. L., Nandwana, V., Abdul, N., Pribus, S. J., Dravid, V. P., Klein, W. L., Disterhoft, J. F., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12087 · Cited by 8
Proteases and Alzheimer’s Disease: Present Knowledge and Emerging Concepts of Therapy
Bernstein, H. (2006) · Springer eBooks · doi:10.1007/0-387-23101-3_1 · Cited by 8
Multifunctional Effects of Human Serum Albumin Toward Neuroprotection in Alzheimer Disease
Ezra, A., Rabinovich-Nikitin, I., Rabinovich‐Toidman, P., & Solomon, B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00011-9 · Cited by 8
Nicholson, A. M., Wold, L. A., Walsh, D. M., & Ferreira, A. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00366 · Cited by 8
Self-citationKim, C. M., Diez, I. P., Bueichekú, E., Ahn, S., Montal, V., & Sepulcre, J. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0488-23.2023 · Cited by 7
Mondal, R., Deb, S., Shome, G., Sarkar, V., Lahiri, D., Datta, S. S., & Benito‐León, J. (2025) · Neurología (English Edition) · doi:10.1016/j.nrleng.2025.03.008 · Cited by 7
Alternative neural circuitry that might be impaired in the development of Alzheimer disease
Ávila, J., Perry, G. L., Strange, B. A., & Hernández, F. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00145 · Cited by 7
Koss, D. J., Robinson, L., Mietelska‐Porowska, A., Gąsiorowska, A., Sepčić, K., Turk, T., Jaspars, M., Niewiadomska, G., Scott, R. H., Platt, B., et al. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1949-4 · Cited by 7
Maltsev, A. V., Dovidchenko, N. V., Uteshev, V. K., Sokolik, V. V., Shtang, O. M., Yakushin, M. A., Sokolova, N. M., Surin, A. K., & Galzitskaya, O. V. (2013) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20135902144 · Cited by 7
Atsmon‐Raz, Y., & Miller, Y. (2015) · Israel Journal of Chemistry · doi:10.1002/ijch.201400162 · Cited by 7
Olesen, M. A., Villavicencio-Tejo, F., Johnson, G. V. W., Porter, G. A., & Quintanilla, R. A. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.02.035 · Cited by 7
Structural biology of cell surface receptors implicated in Alzheimer’s disease
Hermans, S. J., Nero, T. L., Morton, C. J., Gooi, J. H., Crespi, G. A. N., Hancock, N. C., Gao, C., Ishii, K., Markulić, J., & Parker, M. W. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00903-9 · Cited by 6
Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease
Zare, A., Salehi, S., Bader, J. M., Wiessler, A.-L., Prokesch, M., Albrecht, V., Villmann, C., Mann, M., Briese, M., & Sendtner, M. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00499-0 · Cited by 6
Thimmapuram, J., Patel, K. D., Bhatt, D., Chauhan, A., Madhusudhan, D. K., Bhatt, K. K., Deshpande, S., Budhbhatti, U., & Joshi, C. G. (2024) · JMIR Bioinformatics and Biotechnology · doi:10.2196/65506 · Cited by 6
The Biology and Pathobiology of Tau Protein
Hall, G. F. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-788-0_15 · Cited by 6
Towards Small Molecules as Therapies for Alzheimer’s Disease and Other Neurodegenerative Disorders
Aziz, O., Bürli, R. W., Fischer, D. F., Frearson, J. A., & Wall, M. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803959-5.50004-0 · Cited by 6
Garth, F. (2011) · InTech eBooks · doi:10.5772/27973 · Cited by 6
Buchholz, S., Bell, M. J., Kabbani, M. A. A., Kluge, L., Cagkmak, C., Klimek, J., & Zempel, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2277268/v1 · Cited by 6
Peripheral Biomarkers in Dementia and Alzheimer's Disease
Humpel, C., & Marksteiner, J. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9838-3_1 · Cited by 6
Tau Protein Associated Inhibitors in Alzheimer Disease
Li, Q., Chu, T., Chen, Y., & Li, Y. (2014) · Chinese Journal of Chemistry · doi:10.1002/cjoc.201400469 · Cited by 6
Tau and its interactions with other proteins in neurodegenerative diseases
Mroczek, K. H., Annesley, S. J., & Fisher, P. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815950-7.00028-x · Cited by 6
Jury‐Garfe, N., Chimal‐Juárez, E., Patel, H., Martinez‐Pinto, J., Vanderbosch, K., Mardones, M. D., Perkins, A., Prisco, G. V. D., Marambio, Y., Vidal, R., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70238 · Cited by 5
Extracellular Vesicles Play a Central Role in Cerebral Venous Disease‐Associated Brain Atrophy
Wang, J., Li, J., Luo, D., Huang, M., Ao, D., Liu, X., Wang, X., Ge, W., & Zhu, Y. (2023) · Advanced Science · doi:10.1002/advs.202301574 · Cited by 5
Molecular Aspects of Memory Dysfunction in Alzheimer’s Disease
Chin, J., Roberson, E. D., & Mucke, L. (2008) · Elsevier eBooks · doi:10.1016/b978-012370509-9.00015-2 · Cited by 5
Neuronal cell death in human neurodegenerative diseases and their animal/cell models
Martin, L. J., Liu, Z., Troncoso, J. C., & Price, D. L. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511663543.005 · Cited by 5
Methods related to studying tau fragmentation
Ferreira, A., & Afreen, S. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.004 · Cited by 5
Self-citationEmerging Therapeutic Strategies in Alzheimer's Disease
Chiba, T. (2013) · InTech eBooks · doi:10.5772/55293 · Cited by 5
A review on molecular neuropathology of Alzheimer s disease in association with aging
Aka, T. D., Rashid, M. M. O., Paul, S. C., & Halim, M. A. (2018) · Journal of Research in Pharmacy · doi:10.12991/jrp.2018.103 · Cited by 5
RCAN1 and Its Potential Contribution to the Down Syndrome Phenotype
Melanie, A., & Katherine, R. (2013) · InTech eBooks · doi:10.5772/52977 · Cited by 5
Adedayo, B. C., Agunloye, O. M., Obawarrah, R. Y., & Oboh, G. (2024) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2024-0015 · Cited by 5
Sequential Proteolysis by γ-Secretase and Its Implications for Alzheimer’s Disease
Fernandez, M. A. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 5
Sarparast, M., Hinman, J., Pourmand, E., Vonarx, D., Ramirez, L., Ma, W., Liachko, N. F., Alan, J. K., & Lee, K. S. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.02.560527 · Cited by 4
The formation of small aggregates contributes to the neurotoxic effects of tau45-230
Afreen, S., & Ferreira, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105252 · Cited by 4
Self-citationTam, J. H. K., & Pasternak, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801942-9.00004-5 · Cited by 4
Active immunization: A novel therapeutic strategy for treating Alzheimer's disease
Mazahir, F. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178288 · Cited by 4
Alzheimer's Disease Protein Targets: Comprehensive Review and Future Directions
Kumar, B. S. H., Dinesh, B. G. H., Shajan, S. R. O., Sadashivappa, N. M., Ammunje, D. N., Kunjiappan, S., Theivendren, P., & Pavadai, P. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128334916241006195142 · Cited by 4
Jhanji, M., Bhan, A., Arrowood, C. A., Yakout, D. W., Shroff, A., McManus, D., Gifford, H., Vacharasin, J. M., Lizarraga, S. B., Nazarko, T. Y., et al. (2025) · IUBMB Life · doi:10.1002/iub.70030 · Cited by 4
Mohammadi, F., Takalloo, Z., Rahmani, H., Khalili, M. A. N., Khajeh, K., Riazi, G. H., & Sajedi, R. H. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa101 · Cited by 4
Farizatto, K. L. G. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-09122014-133659 · Cited by 4
Genetic influences and neuropathological sequelae of repetitive brain injury
Laskowitz, D. T., & Dawson, H. N. (2014) · Annals of Neurology · doi:10.1002/ana.24057 · Cited by 4
Self-citationGhani, N. S. A., Karjiban, R. A., Basri, M., Faujan, N. H., & Lim, W. Z. (2017) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-016-9570-4 · Cited by 4
Alzheimer's Disease: Approaches to Pathogenesis in the Genomic Age
Sutherland, G. T., & Jillian, J. (2012) · InTech eBooks · doi:10.5772/36505 · Cited by 3
Biomarkers of Alzheimer’s disease
Pitt, J. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404630-6.00048-8 · Cited by 3
Bloom, G. S., & Baas, P. W. (2023) · Cytoskeleton · doi:10.1002/cm.21783 · Cited by 3
Sigurdsson, E. M. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3560-4_8 · Cited by 3
The Search for Biomarkers in Alzheimer's Disease
Meiliana, A., & Wijaya, A. (2010) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v2i1.107 · Cited by 3
Tran, H. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7gb223z · Cited by 3
Ronayne, R. E. (2008) · Digital WPI · Cited by 3
Chai, J.-Y., Zhang, Y. P., Zhang, Z., Ma, D., Cao, Y.-H., Shi-rui, Z. H. U., Yun-zhi, M., Luo, L.-L., Zhan, Y.-L., Fan, Z.-Y., et al. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2026-0041 · Cited by 3
Excitoprotective effects of conditional tau reduction in excitatory neurons and in adulthoodPreprint
Voskobiynyk, Y., Li, Z., Cochran, J. N., Davis, M. N., Carullo, N. V. N., Creed, R. B., Buckingham, S. C., Hall, A. M., Wilson, S. M., & Roberson, E. D. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.14.594246 · Cited by 3
Small, C., Martínez‐Mármol, R., Wallis, T. P., Gormal, R. S., Götz, J., & Meunier, F. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.04.282855 · Cited by 3
Down Syndrome Model of Alzheimer’s Disease: Beyond Trisomy 21Nondisjunction
Granic, A., & Potter, H. (2011) · InTech eBooks · doi:10.5772/24948 · Cited by 3
A surface enhanced Raman spectroscopy platform based on nanoshells for detection of β-amyloid
Beier, H. T., Cowan, C. B., Good, T. A., & Coté, G. L. (2008) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.763888 · Cited by 3
Reconsidering and Reforming the Amyloid Cascade Hypothesis
Uddin, M. S., Kabir, M. T., Behl, T., & Ashraf, G. M. (2021) · Current Protein and Peptide Science · doi:10.2174/1389203722666210322151627 · Cited by 3
Angiotensin-converting enzyme cleavage of the Alzheimer's beta-amyloid peptide
Larmuth, K. (2015) · Open University of Cape Town (University of Cape Town) · Cited by 3
Interplay between synaptic GPCRs in Alzheimer's disease
Martinez-Perez, C. (2019) · Bristol Research (University of Bristol) · Cited by 3
The Inhibitory Effect of OGT Gene Expression on The Level of tau Phosphorylation*
Yang, J.-Y., Gu, J., Shi, J., Liu, F., & Shen, Q. (2009) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2008.00326 · Cited by 3
O’Leary, J. C., Koren, J., & Dickey, C. A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9540-4 · Cited by 2
Cdk5 as a Drug Target for Alzheimer’s Disease
Lau, L., & Hicks, C. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-78887-6_18 · Cited by 2
Report from the Tau Front: Cantoblanco 2013
Hall, G. F. (2014) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000e133 · Cited by 2
Misfolded Proteins in Neurodegenerative Dementias: Molecular Mechanisms
Yang, H. D., Ho, D. H., Yi, M. J., Seol, W., & Kim, S. (2012) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2012.11.2.38 · Cited by 2
Natural antioxidants in prevention and management of Alzheimer's disease
Zhao, Y. M. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/516 · Cited by 2
Amyloid Beta: The Foremost Protagonist in Alzheimer's Disease
Anand, A., Sharma, N., Gulati, M., & Khurana, N. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-5282-6.ch011 · Cited by 2
El-Baga, S. E., Hassan, M. H., Awadalla, E. A., & El-Kader, A. E.-K. M. A. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04692-z · Cited by 2
ROLE OF SOD AND CATHEPSIN-D IN ALZHEIMER’S DISEASE Aβ CASCADE MODELS
Lobdell, G. M., & Donahue, M. K. (2011) · Digital WPI · Cited by 2
Metadata
- Authors
- Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A.
- Affiliations
- Northwestern University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-04-16
- Volume
- 99
- Issue
- 9
- Pages
- 6364-6369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC122954
- OpenAlex
- W2081768153
- Cited by
- 807
- References
- 45
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 22 · 2023: 24 · 2022: 22 · 2021: 25 · 2020: 44 · 2019: 37 · 2018: 40 · 2017: 43 · 2016: 39 · 2015: 40 · 2014: 55 · 2013: 44 · 2012: 51
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag015383-02)
- National Institute on Aging (AG15383)
- National Institute of Neurological Disorders and Stroke (R01NS039080, NS 39080)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tau protein, amyloid-beta, Alzheimer's disease, neurotoxicity, neurite degeneration, hippocampal neurons, microtubules, cytoskeleton, amyloid plaques, neurofibrillary tangles, amyloid fibrils
- MeSH terms
- Animals, Brain, Central Nervous System, Cytoskeleton, Hippocampus, Humans, Immunohistochemistry, Mice, Transgenic, Microtubules, Phenotype, Immunoblotting, Blotting, Western, Amyloid beta-Peptides, tau Proteins, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.